Universe Pharmaceuticals INC announces strategic alliance with Jinggangshan University for a study on the chemical constituents of certain traditional Chinese medicines


Ji’an, Jiangxi, China, December 29, 2021 (GLOBE NEWSWIRE) – Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company has entered into a strategic cooperation agreement (the “Agreement”) with Jinggangshan University (“JGSU”), a public university located in Ji’an City in Jiangxi Province, for a study of the chemical constituents of Liparis Odorata, a traditional Chinese medicine, for the treatment of hyperlipidemia.

Under the Agreement, JGSU undertakes to conduct the aforementioned studies and to provide the results of scientific research to the Company, and to report to the Company upon their completion within 24 months from the date of the Agreement. .

Mr. Gang Lai, CEO of Universe Pharmaceuticals INC, said, “We are delighted to collaborate with JGSU on this research partnership, as JGSU has an impressive track record of leading edge research in studies of Chinese medicines, as well as its expertise and resources. will be precious to us. It is essential that pharmaceutical companies and academic institutions work together to develop Chinese medicine for diseases with a large market and unmet medical needs, and JGSU is one of the ideal partners to support us in this effort. By working with JGSU, we hope to be at the forefront of Chinese drug development with better efficiency and better market recognition. “

On Jinggangshan University

Established in 1958 and located in the Jinggangshan Mountains in Qingyuan District, Ji’an City, Jiangxi Province, China, JGSU is jointly supported by the Ministry of Education of the People’s Republic of China and the People’s Government. from Jiangxi Province and attended by two Tongji Universities. In July 2003, approved by the Ministry of Education of the People’s Republic of China, Jinggangshan Normal University was renamed Jinggangshan University by joining Jinggangshan College of Medicine and Jinggangshan Vocational Technical College. Jinggangshan University Faculty of Medicine has 3A Affiliate Hospital, Jinggangshan University Affiliate Hospital, which consists of 35 medical departments and sections and is listed in the World Health Organization, the Foundation for the Advancement of International Medical Education and Research (FAIMER), the Geneva Foundation for Medical Education and Research (GFMER), as well as the AVICENNA Directory for Medicine. For more information, visit the company’s website at http://www.jgsu.edu.cn/.

About Universe Pharmaceuticals INC

Universe Pharmaceuticals INC, headquartered in Ji’an, Jiangxi, China, is a manufacturer and distributor of pharmaceuticals in China. The Company specializes in the manufacture, marketing, sale and distribution of products derived from traditional Chinese medicine targeting the elderly with the aim of remedying their physical conditions related to the aging process and promoting their general well-being. . The Company also distributes and sells biomedical drugs, medical instruments, pieces of traditional Chinese medicine, and dietary supplements manufactured by third-party pharmaceutical companies. Currently, the Company’s products are sold to 30 provinces in China. For more information, visit the company’s website at http://www.universe-pharmacy.com/.

Forward-looking statements

All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections regarding future events and financial trends which, in the opinion of the Company, could affect its financial condition, results of operations and strategy. business and financial needs. Investors may identify these forward-looking statements by words or phrases such as “may”, “will”, “expect”, “anticipate”, “aim”, “estimate”, “intend”, ” plan ”,“ believe ”,“ potential ”,“ continue ”,“ is / are likely to ”or other similar expressions. The Company assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances, or changes in its expectations, except as required by law. While the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot guarantee that such expectations will prove to be correct, and the Company cautions investors that actual results may differ materially from anticipated results and encourages investors to review d ” other factors that may affect its future results in the company’s registration statement and in its other documents filed with the SEC.

For more information please contact:

Ascent Investor Relations LLC
Tina Xiao
President
Telephone: 917-609-0333
Email: [email protected]


Comments are closed.